Vinci Pharmaceuticals

Vinci Pharmaceuticals is disrupting retinal disease treatment with EPIPLANT™, a proprietary needle free drug delivery platform.

Amount raised

$8M

Round

Series A

Date raised

October 8, 2026

Founded

—

CompanyVinci Pharmaceuticals

IndustryBiotechnology

InvestorsDynagrow Capital, LLLP

Founder

Free weekly list of newly funded startups and their founders.

Vinci Pharmaceuticals is disrupting retinal disease treatment with EPIPLANT™, a proprietary needle free drug delivery platform.

How much did Vinci Pharmaceuticals raise?: Vinci Pharmaceuticals raised $8M in a Series A round on October 8, 2026. Investors include Dynagrow Capital, LLLP.
Who founded Vinci Pharmaceuticals?: Karl Csaky founded Vinci Pharmaceuticals.